The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/22082
StudyName: CRFs Cabazitaxel Prostate Cancer DRKS00006520 NCT01308580 Cycle 2
Date of export from the portal: 02.07.2020
Date of Upload / last change: 18.05.2017
License: Creative Commons BY 4.0

----

Description: 
Randomized, Open Label Multi-Center Study Comparing Cabazitaxel at 20 mg/m² and at 25 mg/m² Every 3 Weeks in Combination With Prednisone for the Treatment of Metastatic Castration Resistant Prostate Cancer Previously Treated With a Docetaxel-Containing Regimen
Other drug name: Jevtana®

Study Source & Descriptions:
https://clinicaltrials.gov/ct2/show/NCT01308580
Sponsor: Sanofi

